{"id":7359,"date":"2017-04-21T23:40:07","date_gmt":"2017-04-21T23:40:07","guid":{"rendered":"http:\/\/www.denverpost.com\/?p=2624197"},"modified":"2017-04-21T23:40:07","modified_gmt":"2017-04-21T23:40:07","slug":"study-national-medical-marijuana-laws-would-save-lives-and-a-billion-taxpayer-dollars","status":"publish","type":"post","link":"https:\/\/cannitrol.com\/blog\/study-national-medical-marijuana-laws-would-save-lives-and-a-billion-taxpayer-dollars\/","title":{"rendered":"Study: National medical marijuana laws would save lives \u2014 and a billion taxpayer dollars"},"content":{"rendered":"<div id=\"wp_fb_like_button\" style=\"margin:5px 0 5px 5px;float:right;height:100px;\"><script src=\"http:\/\/connect.facebook.net\/en_US\/all.js#xfbml=1\"><\/script><fb:like href=\"https:\/\/cannitrol.com\/blog\/study-national-medical-marijuana-laws-would-save-lives-and-a-billion-taxpayer-dollars\/\" send=\"true\" layout=\"standard\" width=\"450\" show_faces=\"false\" font=\"arial\" action=\"like\" colorscheme=\"light\"><\/fb:like><\/div><div class=\"row\">\n<div class=\"large-10 large-centered small-12 columns\">\n<div class=\"entry-meta-date\">Published: Apr 21, 2017, 10:56 am \u2022 Updated: Apr 21, 2017, 1:10 pm<span class=\"single-comments-link\"><a href=\"http:\/\/www.thecannabist.co\/2017\/04\/21\/medical-marijuana-healthcare-costs-prescriptions\/77899\/#disqus_thread\" class=\"commentsNameLink\" \/><\/span><\/div>\n<p class=\"byline\">By <strong>Christopher Ingraham<\/strong>, <em> The Washington Post<\/em><\/p>\n<p>A <a href=\"http:\/\/www.thecannabist.co\/2016\/07\/07\/medical-marijuana-lower-prescription-drug-use\/57732\/\">fascinating study in Health Affairs last year<\/a> by a father-daughter pair of public policy researchers found that Medicare prescriptions for things like painkillers, antidepressants and anti-anxiety medications dropped sharply in states that introduced a medical marijuana program.<\/p>\n<p>The implication? Offered the choice between taking medication prescribed by a doctor and self-medicating with pot, many older patients opted for the latter.<\/p>\n<p>But the study left one big question unanswered: Since the study\u2019s authors \u2013 the University of Georgia\u2019s Ashley Bradford and W. David Bradford \u2013 only looked at Medicare data, they couldn\u2019t say for sure whether the findings held for younger patients too.<\/p>\n<p>Now, we\u2019re getting more answers. This week, the Bradfords are back with <a href=\"http:\/\/content.healthaffairs.org\/content\/early\/2017\/04\/13\/hlthaff.2016.1135\">a new study applying the same analysis to prescriptions under Medicaid<\/a>, which covers low-income people of all ages. The results largely validate their previous work: Medicaid prescriptions for certain drugs fell significantly in states that adopted a medical marijuana law.<\/p>\n<p>Specifically, anti-nausea drug prescriptions fell by 17 percent. Anti-depressant prescriptions fell 13 percent, while prescriptions for seizure and psychosis drugs fell 12 percent.<\/p>\n<p>Not everyone who has access to medical marijuana opts for it, obviously. But enough do to make a significant dent in the prescription numbers. \u201cPatients and physicians in the community are reacting to the availability of medical marijuana as if it were medicine,\u201d the Bradfords conclude.<\/p>\n<p>Perhaps most significantly from a public health standpoint, prescriptions for painkillers fell by 11 percent. Opiate painkillers are behind much of the current drug overdose epidemic.<\/p>\n<p>Numerous studies have found that opiate abuse and <a href=\"http:\/\/www.thecannabist.co\/2017\/03\/01\/sessions-marijuana-opioid-research\/74584\/\">overdose rates fell in states with medical marijuana laws<\/a>. The Bradfords\u2019 research describes the mechanism by which that could happen: the introduction of medical marijuana laws coincides with a drop in painkiller prescriptions.<\/p>\n<p>The Bradfords\u2019 data only include prescriptions made under Medicare and Medicaid, but given the totality of their evidence it seems reasonable to assume that similar patterns hold true for patients on private insurance plans.<\/p>\n<p>In the current budgetary environment, no analysis of healthcare is complete without a discussion of costs. The Bradfords estimate that because of the drops in prescribing rates, a nationwide medical marijuana program would save taxpayers about $1.1 billion on Medicaid prescriptions annually. That\u2019s on top of the the half a billion in Medicare savings the Bradfords estimated last year.<\/p>\n<p>Those costs don\u2019t evaporate into thin air, of course: they would simply be shifted over to seniors and low-income people who would be purchasing medical marijuana outside of their insurance programs.<\/p>\n<p>There\u2019s also the open question of how smart it is from a personal health perspective to be self-medicating with pot: \u201cit is plausible that forgoing medications with known safety, efficacy, and dosing profiles in favor of marijuana could be harmful under some circumstances,\u201d the Bradfords warn.<\/p>\n<p>Still, the Bradfords\u2019 research makes the gulf between <a href=\"http:\/\/www.thecannabist.co\/2017\/01\/12\/marijuana-research-review-united-states-health-benefits-risks-future\/71204\/\">our current medical understanding of marijuana<\/a> and federal policy around it even wider. Last summer the DEA affirmed yet again marijuana\u2019s status in Schedule 1 of the controlled substances act, a category reserved for the most dangerous, addictive drugs that have no medical applications.<\/p>\n<p>\u201cThis decision was made despite the substantial and growing evidence that the requirements for Schedule I status involving \u2018no currently accepted medical uses\u2019 are no longer met by marijuana,\u201d the Bradfords write.<\/p>\n<\/p><\/div>\n<\/p><\/div>\n<p><!-- .row --> <\/p>\n","protected":false},"excerpt":{"rendered":"<p>A fascinating study in Health Affairs last year by a father-daughter pair of public policy researchers found that Medicare prescriptions for things like painkillers, antidepressants and anti-anxiety medications dropped sharply in states that introduced a medical marijuana program. <\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[6811,6813,77,7093,56,511,9,5019,6983,2387,1,3,61,1736],"tags":[6816,6818,2655,7094,2636,3085,5022,6984,4951],"_links":{"self":[{"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/posts\/7359"}],"collection":[{"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/comments?post=7359"}],"version-history":[{"count":0,"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/posts\/7359\/revisions"}],"wp:attachment":[{"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/media?parent=7359"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/categories?post=7359"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/tags?post=7359"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}